Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Consolidated Net Income (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Consolidated Net Income for 9 consecutive years, with $136.0 million as the latest value for Q4 2025.

  • Quarterly Consolidated Net Income rose 286.23% to $136.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $145.3 million through Dec 2025, up 171.7% year-over-year, with the annual reading at $145.4 million for FY2025, 171.77% up from the prior year.
  • Consolidated Net Income hit $136.0 million in Q4 2025 for Inspire Medical Systems, up from $9.9 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $136.0 million in Q4 2025 to a low of -$16.8 million in Q3 2022.
  • Historically, Consolidated Net Income has averaged $4.5 million across 5 years, with a median of -$6.1 million in 2023.
  • Biggest five-year swings in Consolidated Net Income: surged 369.62% in 2023 and later plummeted 137.27% in 2025.
  • Year by year, Consolidated Net Income stood at -$2.3 million in 2021, then skyrocketed by 234.44% to $3.2 million in 2022, then soared by 369.62% to $14.8 million in 2023, then surged by 138.11% to $35.2 million in 2024, then surged by 286.23% to $136.0 million in 2025.
  • Business Quant data shows Consolidated Net Income for INSP at $136.0 million in Q4 2025, $9.9 million in Q3 2025, and -$3.6 million in Q2 2025.